The India DNA testing market size reached USD 300.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 670.0 Million by 2033, exhibiting a growth rate (CAGR) of 7.68% during 2025-2033. The market is driven by rising prevalence of genetic disorders, increasing demand for personalized medicine, growing awareness about ancestry and health-related genetic testing, advancements in genomic technologies, and numerous government initiatives supporting biotechnology, making DNA testing more accessible and affordable for early disease detection, diagnosis, and treatment planning.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 300.0 Million |
Market Forecast in 2033 | USD 670.0 Million |
Market Growth Rate 2025-2033 | 7.68% |
Increasing Prevalence of Genetic Disorders and Chronic Diseases
The growing prevalence of genetic disorders and chronic diseases in India has led to a rising need for sophisticated diagnostic tools, such as DNA testing. Genetic disorders like thalassemia, sickle cell anemia, and specific inherited cancers are of specific concern. Early detection by means of genetic testing allows for early intervention, tailored treatment protocols, and informed reproductive decisions. As per the Department of Biotechnology's Annual Report 2021, an effort has been made toward dealing with genetic disorders through R&D activities. The report points toward progress in diagnostic technology and therapeutic approaches to reducing the effects of these disorders. Additionally, the National Biotechnology Development Strategy 2021-25 lays out the government's pledge to develop the biotechnology industry, which includes genetic testing services. The strategy looks to improve the delivery of healthcare by incorporating the use of modern biotechnological tools, and thus the treatment of genetic disorders and chronic conditions. The growing prevalence of chronic diseases, including cardiovascular ailments and diabetes, also fuels the need for genetic testing. Determining genetic predispositions allows individuals to implement preventive strategies and clinicians to individualize treatment protocols appropriately. This individualized approach not only enhances patient outcomes but also maximizes healthcare resources.
Technological Advancements in Genetic Testing
Innovations in technology have tremendously increased the precision, access, and price affordability of genetic testing in India. Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR)-based diagnostic innovations have completely changed the arena of work to encompass full-scale genomic studies at lesser expenses. Indian Biological Data Centre (IBDC) is an integrated repository providing a wide range of biological datasets such as nucleotide sequences and proteomic data. This centralized platform makes research and development in genetic testing possible and allows for the development of more effective diagnostic tools. Furthermore, the Central Drugs Standard Control Organisation (CDSCO) has streamlined the process for the approval of recombinant DNA (r-DNA) origin drugs, promoting a positive climate for innovation in genetic testing technology. The organization’s January 2025 updated list of approved r-DNA origin drugs is a manifestation of the rising uptake of state-of-the-art biotechnological products in the healthcare system. These technological innovations not only enhanced the quality of genetic testing but also made it accessible to a larger population. As the cost declines further and precision escalates, the uptake of genetic testing is anticipated to penetrate further, driving the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on product type, technology, and application.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment (DNA analyzers, PCR (Polymerase Chain Reaction) machines, sequencers, electrophoresis systems, and others), consumables (reagents and kits, PCR consumables (primers, probes), DNA extraction kits, sample collection devices, and others), software (data analysis software, laboratory information management system (LIMS), genetic analysis software, bioinformatics software, and others), services (testing services (genetic testing, forensic testing, and others), data interpretation services, consultation services (genetic counseling), laboratory services (sample processing, DNA sequencing services), and others.
Technology Insights:
A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes polymerase chain reaction (PCR) based, in-situ hybridization, microarray, and next-generation sequencing (NGS) DNA diagnosis.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes newborn DNA screening, pre-natal DNA carrier screening, oncology diagnostics and histopathology, pre-implantation diagnosis, infectious disease diagnostics, pharmacogenomics diagnostic testing, identify diagnostics and forensic, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered |
|
Technologies Covered | Polymerase Chain Reaction (PCR) Based, In-Situ Hybridization, Microarray, Next-Generation Sequencing (NGS) DNA Diagnosis |
Applications Covered | Newborn DNA Screening, Pre-Natal DNA Carrier Screening, Oncology Diagnostics and Histopathology, Pre-Implantation Diagnosis, Infectious Disease Diagnostics, Pharmacogenomics Diagnostic Testing, Identify Diagnostics and Forensic, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: